Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.